|
U.S. FDA: Artificial Pancreas Guidelines Will Encourage Device’s Development
The U.S. Food and Drug Administration (FDA) intends a new draft guidance on development of artificial pancreas device systems to be a map rather than a roadblock, an FDA official said in a Dec. 1 briefing.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives